20-OR: The Renal and Vascular Effects of Combined SGLT2 and Angiotensin Converting Enzyme Inhibition
Yuliya Lytvyn(University Health Network), DAVID CHERNEY, Karen Kimura(Boehringer Ingelheim (Canada)), BRUCE A. PERKINS, Leslie Cham(University Health Network), VESTA S. LAI, Josephine Tse(University Health Network), Nuala Peter(Thrombosis Research Institute), Nima Soleymanlou(Boehringer Ingelheim (Canada))
Cited by 0
Related Papers
Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis
|Circulation|2013|930
Sodium Glucose Cotransporter-2 Inhibition in Heart Failure
|Circulation|2017|470
Glycosuria-mediated urinary uric acid excretion in patients with uncomplicated type 1 diabetes mellitus
|American Journal of Physiology-Renal Physiology|2014|173
The New Biology of Diabetic Kidney Disease—Mechanisms and Therapeutic Implications
|Endocrine Reviews|2019|171